Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
16.99
+0.59 (3.60%)
At close: Oct 15, 2025, 4:00 PM EDT
17.20
+0.21 (1.24%)
After-hours: Oct 15, 2025, 5:33 PM EDT
Roivant Sciences Stock Forecast
Stock Price Forecast
The 8 analysts that cover Roivant Sciences stock have a consensus rating of "Strong Buy" and an average price target of $19.94, which forecasts a 17.36% increase in the stock price over the next year. The lowest target is $16 and the highest is $24.
Price Target: $19.94 (+17.36%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Roivant Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +41.26% | Sep 18, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +17.72% | Sep 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +17.72% | Sep 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $15 → $21 | Strong Buy | Maintains | $15 → $21 | +23.60% | Sep 18, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $18 → $22 | Buy | Maintains | $18 → $22 | +29.49% | Sep 18, 2025 |
Financial Forecast
Revenue This Year
23.18M
from 29.05M
Decreased by -20.23%
Revenue Next Year
69.74M
from 23.18M
Increased by 200.91%
EPS This Year
-1.44
from -0.24
EPS Next Year
-1.43
from -1.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 49.6M | 228.3M | |||
| Avg | 23.2M | 69.7M | |||
| Low | 8.8M | 8.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 70.6% | 885.1% | |||
| Avg | -20.2% | 200.9% | |||
| Low | -69.6% | -61.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.24 | -0.93 | |||
| Avg | -1.44 | -1.43 | |||
| Low | -2.02 | -1.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.